Provided by Tiger Fintech (Singapore) Pte. Ltd.

Petros Pharmaceuticals Inc

0.0540
+0.00285.47%
Post-market: 0.0527-0.0013-2.41%19:53 EDT
Volume:2.62M
Turnover:136.19K
Market Cap:2.89M
PE:-0.02
High:0.0545
Open:0.0496
Low:0.0496
Close:0.0512
Loading ...
Apr 11, 2025

Major Issues Report

Form 8-K - Current report
Apr 09, 2025

Major Issues Report

Form 8-K - Current report
Apr 01, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2025

Major Issues Report

Form 8-K - Current report
Feb 15, 2025

Correspondence

Form CORRESP - Correspondence
Feb 15, 2025

Correspondence

Form CORRESP - Correspondence
Feb 15, 2025

Correspondence

Form CORRESP - Correspondence
Feb 15, 2025

Correspondence

Form CORRESP - Correspondence
Feb 14, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 13, 2025

Correspondence

Form CORRESP - Correspondence
Feb 13, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 12, 2025

Correspondence

Form CORRESP - Correspondence
Feb 11, 2025

Correspondence

Form CORRESP - Correspondence
Feb 10, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 24, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 24, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]